Skip to main content

No Link Between Cell Phone Use and Cancer


In recent years, people have been whipsawed by conflicting studies about the risks posed by low levels of radiation given off by cell phones.

Now, one of the largest and longest-running studies ever to look for a link between mobile phone use and brain tumors shows that cell phone use doesn't increase the risk of brain cancer and other kinds of central nervous system cancers.

The study was conducted in Denmark, a country that's unique because it keeps extraordinary health records on its residents. It's published in the journal BMJ.

Researchers used the country's detailed databases to find out if adults with cell phone contracts before 1995 got brain tumors more frequently that those who didn't subscribe to mobile services.

Because the study stretches back decades, researchers say many of these subscribers were probably using early-generation cell phones that emitted more radiation than newer phones.

Over an 18-year period, 10,729 cancers of the brain and central nervous system were diagnosed;9,883 of these were in 3.2 million Danes in the general population who were thought not to use cell phones and 846 were diagnosed in 358,403 people with cell phone contracts.

The risk of getting a brain tumor was essentially no different between the two groups.

That remained true even when researchers looked just at adults who'd had cell phones contracts the longest, for more than 13 years, and when researchers looked at specific tumor types.

"We didn't find any association," says researcher Patrizia Frei, PhD, who was a postdoctoral research fellow at the Institute of Cancer Epidemiology at the Danish Cancer Society in Copenhagen when the study was conducted.

So, Cell Phones Safe or Not?

Federal health agencies, including the FDA, CDC, and National Cancer Institute, have stated that the balance of the evidence shows that cell phones probably don't cause any health problems.

But because so many people use them -- more than 87% of the U.S. population had a mobile phone in 2008 -- these agencies also agree that more research is needed.

In May, a panel of experts convened by the World Health Organization reviewed the evidence and ruled that radiation from cell phones could "possibly" cause cancer, putting the risk posed by cell phones on par with pesticides, some food dyes, and heavy metals.

Jonathan Samet, MD, a professor of preventive medicine at the University of Southern California's Keck School of Medicine, in Los Angeles, who led that panel, says these new findings wouldn't have changed their ruling.

"While this study does not show any association, it does not establish "safety" -- that is, the absence of risk," Samet says in an email. "This is a useful addition to the literature, and we need more studies of high quality."

Swiss researchers who wrote an editorial on the study said it had important strengths that should further reassure cell phone users.

Perhaps the biggest advantage was because it used large databases, the study did not need to rely on people to remember details about their cell phone use. Faulty memory can be a major source of inaccurate information in studies.

Why More Research Is Needed

One weakness, though, was that the study used mobile phone contracts as a way to estimate use.

Just having a cell phone contract doesn't mean a person is using a phone regularly, and some people who don't have contracts will have pay-as-you-go phones.

"The resulting misclassification would dilute any association between mobile phone use and cancer risk, and this is important for a ... study like the current one," says Anders Ahlbom, professor of environmental medicine at Karolinska Institute in Stockholm, Sweden, in an editorial.

Researchers agree that this study should not be the final word.

"Our study can't answer all the questions," says Frei. For example, she says questions remain about risks associated with continued long-term use of cell phones, for longer than 20 years. And there's been little information about the use of cell phones in children, she says.

"We couldn't say that we've solved all the problems so far. I would still say that we have some limited evidence," she says.

Source:
rxlist.com

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

The Classification of Blood pressure has been changed!!!